TNF-alpha inhibitor
This page covers all TNF-alpha inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TNF-alpha, TNF-alpha (Tumor Necrosis Factor-alpha), TNF-α (tumor necrosis factor-alpha).
Targets
TNF-alpha · TNF-alpha (Tumor Necrosis Factor-alpha) · TNF-α (tumor necrosis factor-alpha) · TNF-alpha (tumor necrosis factor-alpha) · Tumour necrosis factor-alpha
Marketed (7)
- Certolizumab Pegol (CZP) · UCB Pharma · Immunology
Certolizumab pegol is a TNF-alpha inhibitor that binds to and neutralizes tumor necrosis factor-alpha, reducing inflammatory signaling. - TDM-based infliximab intravenous therapy · Asan Medical Center · Immunology
Infliximab is a TNF-alpha inhibitor monoclonal antibody that binds and neutralizes tumor necrosis factor-alpha, reducing inflammatory responses in autoimmune and inflammatory diseases. - Infliximab Adalimumab y Golimumab · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Immunology
These are TNF-alpha inhibitors that block tumor necrosis factor-alpha, a key inflammatory cytokine driving immune-mediated diseases. - TNF alpha inhibitors · Prof. Roberto Giacomelli · Immunology
TNF alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine that drives immune-mediated inflammation. - etanercept or adalimumab · University of Glasgow · Immunology
TNF-alpha inhibitors that block tumor necrosis factor-alpha signaling to reduce inflammation in autoimmune and inflammatory diseases. - infliximab, etanercept, adalimumab · University Hospital, Strasbourg, France · Immunology
These drugs are TNF-alpha inhibitors that block tumor necrosis factor-alpha, a key inflammatory cytokine driving immune-mediated diseases. - Adalimumab, etanercept, infliximab · University of Padova · Immunology
These are TNF-alpha inhibitors that block tumor necrosis factor-alpha, a key inflammatory cytokine driving immune-mediated diseases.
Phase 3 pipeline (16)
- OLE FD Adalimumab +/- MTX · Abbott · Immunology
Adalimumab is a TNF-alpha inhibitor that blocks tumor necrosis factor-alpha signaling to reduce inflammation, with optional methotrexate co-administration to enhance efficacy. - Adalimumab Every Week · Innovaderm Research Inc. · Immunology
Adalimumab is a TNF-alpha inhibitor monoclonal antibody that blocks tumor necrosis factor-alpha to reduce inflammation and immune-mediated disease activity. - infliximab infusion; AZA placebo caps · Centocor Ortho Biotech Services, L.L.C. · Immunology
Infliximab is a chimeric monoclonal antibody that binds to tumor necrosis factor-alpha (TNF-alpha), preventing its interaction with cell surface TNF receptors and thereby inhibiting the inflammatory response. - Certolizumab pegol (CDP870) · UCB Pharma · Immunology
Certolizumab pegol is a TNF-alpha inhibitor that binds to and neutralizes tumor necrosis factor-alpha, reducing inflammatory signaling. - CDP870 · Otsuka Pharmaceutical Co., Ltd. · Immunology
CDP870 is a pegylated TNF-alpha inhibitor that binds and neutralizes tumor necrosis factor-alpha to reduce inflammatory responses. - EU-approved Humira · Celltrion · Immunology
Humira is a TNF-alpha inhibitor that blocks tumor necrosis factor-alpha, a key inflammatory cytokine driving autoimmune and inflammatory diseases. - placebo adalimumab, placebo MTX · Abbott · Immunology
Adalimumab is a monoclonal antibody that binds to tumor necrosis factor-alpha (TNF-alpha), preventing its interaction with cell surface TNF receptors and thereby reducing inflammation. - etanercept Treatment · Assistance Publique Hopitaux De Marseille · Immunology
Etanercept is a tumor necrosis factor-alpha (TNF-alpha) inhibitor that works by binding to TNF-alpha and preventing it from interacting with its receptors on cell surfaces. - Simponi (Golimumab) · Alvotech Swiss AG · Immunology
Simponi (Golimumab) is a monoclonal antibody that selectively binds to and inhibits tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. - Open-labelAdalimumabRescue · Abbott · Immunology
Adalimumab is a TNF-alpha inhibitor that blocks tumor necrosis factor-alpha to reduce inflammation and immune-mediated disease activity. - OLE BSA Adalimumab +/- MTX · Abbott · Immunology
Adalimumab is a TNF-alpha inhibitor that blocks tumor necrosis factor-alpha signaling to reduce inflammation, with optional methotrexate co-administration to enhance efficacy. - US-licensed Humira · Celltrion · Immunology
Humira is a monoclonal antibody that targets and binds to tumor necrosis factor-alpha (TNF-alpha), preventing it from interacting with its cell surface receptor and thereby reducing inflammation. - SB27 · Samsung Bioepis Co., Ltd. · Rheumatology
SB27 is a biosimilar to adalimumab, a TNF-alpha inhibitor. - SC golimumab · Merck Sharp & Dohme LLC · Immunology
SC golimumab is a monoclonal antibody that binds to tumor necrosis factor-alpha (TNF-alpha), preventing its interaction with cell surface TNF receptors and subsequent inflammatory response. - EU Simponi · Bio-Thera Solutions · Immunology
Simponi is a TNF-alpha inhibitor that blocks tumor necrosis factor signaling to reduce inflammation in autoimmune diseases. - Adalimumab biosimilar · Alvotech Swiss AG · Immunology
Adalimumab biosimilar is a TNF-alpha inhibitor that binds to and neutralizes tumor necrosis factor-alpha, reducing inflammatory signaling.
Phase 2 pipeline (10)
- Anti TNF therapy including infliximab · Janssen Biotech, Inc. · Immunology
Blocks tumor necrosis factor-alpha (TNF-alpha) by binding to it and preventing it from interacting with cell surface TNF receptors. - L19TNF and TMZ · Philogen S.p.A. · Oncology
TNF-alpha inhibitor - Anti TNF Alfa. · Carmel Medical Center · Immunology
Anti TNF Alfa works by binding to and inhibiting tumor necrosis factor-alpha, a cytokine involved in systemic inflammation. - Anti-TNF agents · Altuğ Güner · Immunology
Anti-TNF agents work by binding to and inhibiting tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine involved in systemic inflammation. - Infliximab; Gemcitabine · Centocor, Inc. · Immunology
Infliximab is a chimeric monoclonal antibody that binds to tumor necrosis factor-alpha (TNF-alpha), preventing its interaction with cell surface TNF receptors. - Anti-TNF Drug · Schneider Children's Medical Center, Israel · Immunology
Anti-TNF drugs block the action of tumor necrosis factor-alpha (TNF-alpha), a protein involved in systemic inflammation. - Adalimumab, new formulation · AbbVie (prior sponsor, Abbott) · Immunology
Adalimumab is a monoclonal antibody that binds to and inhibits tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. - AMG102 · UNICANCER · Oncology
AMG102 is a recombinant human tumor necrosis factor (TNF) receptor fusion protein. - Adalimumab PFS and Pen · Samsung Bioepis Co., Ltd. · Immunology
TNF-alpha inhibitor - Adalimumab, current formulation · AbbVie (prior sponsor, Abbott) · Immunology
Tumor necrosis factor-alpha inhibitor
Phase 1 pipeline (5)
- Adverse Reactions of Enbrel subcutaneously · ASIS Corporation · Immunology
Tumor necrosis factor-alpha inhibitor - Adalimumab-US · Pfizer · Immunology
Tumor necrosis factor-alpha inhibitor - Adalimumab European source · Synermore Biologics Co., Ltd. · Immunology
Tumour necrosis factor-alpha inhibitor - Adalimumab ID · Centre for Human Drug Research, Netherlands · Immunology
Tumour necrosis factor-alpha inhibitor - Adalimumab SC · Centre for Human Drug Research, Netherlands · Immunology
Tumour necrosis factor-alpha inhibitor